Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02483832 · ClinicalTrials.gov registry record · NA
Message Framing and Colorectal Cancer Screening
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 640
- Enrollment target
NCT02483832: Completed NA study, sponsored by Duke University.
NCT02483832 is a NA study that has completed, run by Duke University. The registered enrollment target is 640 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (54% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02483832, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 640 participants
- Enrollment target
Study Summary
The main purpose of this study is to promote colorectal cancer (CRC) screening among individuals who have never been screened, with these individuals being members of a panel who participant in online studies. The primary study goals are to test effects of the matching between level of comparative risk feedback for colorectal cancer (CDC), that is, how one's risk compares to others, and message framing (Gain vs. loss frame) on CRC screening intentions and screening as well as mediators of effects in the context of people who obtain CRC risk feedback and framing messages online (i.e., Internet).
Primary Outcome
Respondents will be required to complete a six-month follow-up survey and answer questions about any CRC screening they have sought out and/or completed since the intervention.
Interventions
- BEHAVIORAL Educational materials
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 640 participants |
| Start Date | 2015-02 |
| Est. Completion | 2015-08-24 |
| Phase | NA |
What the finished NCT02483832 record still lists
NCT02483832 is an interventional study that assigns participants to a tested intervention. The registered 640 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (54% lower).
The record links to 0 conditions, and to 1 intervention - of which Educational materials is the first listed.
NCT02483832 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02483832 about?
NCT02483832 is a clinical study titled "Message Framing and Colorectal Cancer Screening". The main purpose of this study is to promote colorectal cancer (CRC) screening among individuals who have never been screened, with these individuals being members of a panel who participant in online studies. The primary study goals are to test effects of the matching between level of comparative r...
What is the current status of trial NCT02483832?
This trial is currently completed. It is a NA study. The enrollment target is 640 participants. The study started on 2015-02. Estimated completion is 2015-08-24.
What interventions are being tested in trial NCT02483832?
The interventions under investigation include: Educational materials (BEHAVIORAL).
Who is sponsoring clinical trial NCT02483832?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02483832's enrollment target sits among peer trials
640 156th of 2000 higher than 1,844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04339699 · 640 participants · NA
NobleStitch EL STITCH Trial is a PFO Comparative Trial
- NCT04979338 · 640 participants · Phase 3
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
- NCT05156398 · 640 participants · Phase 3
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- NCT05930483 · 640 participants · NA
Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia